Fifty shades of pink: new pink cell tumors of the kidney

Fifty shades of pink: new pink cell tumors of the kidney is organized by Opus Medicus, Inc.

Last Review Date: 17-Nov-2022
Expiration Date: 16-Nov-2025

Description:
This course describes the pathologic features and criteria for diagnosis of newly described "pink" tumors of the kidney.

Objectives:

• Identify a predominant pattern of pink cell renal tumors at low power.
• Generate differential diagnosis based on the predominant pattern.
• Rule in or out each tumor on the list by looking for a constellation of histological features relatively specific for the tumor.

Topics:

• TFEB-amplified renal cell carcinoma
• Succinate Dehydrogenase (SDH) Deficient RCC
• Fumarate Hydratase (FH)-deficient Renal Cell Carcinoma in Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC)
• Oncocytoma
• Translocation renal cell carcinoma
• TSC-mTOR mutated RCC
• Eosinophilic solid cystic (ESC) RCC with somatic TSC2 mutation
• Renal Cell Carcinoma in Tuberous Sclerosis Complex

1.0 AMA PRA Category 1 Credit™ | 1.0 MOC